Last update 11 Jul 2024

Aclarubicin Hydrochloride

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Aclacinomycin A, Aclarubicin, Aclarubicin Hydrochlorid
+ [8]
Mechanism
DNA inhibitors(DNA inhibitors), Top II inhibitors(Topoisomerase II inhibitors)
Active Indication
Inactive Indication-
Originator Organization
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
JP (04 Jun 1981),
Regulation-
Login to view First Approval Timeline

Structure

Molecular FormulaC42H53NO15
InChIKeyUSZYSDMBJDPRIF-SVEJIMAYSA-N
CAS Registry57576-44-0
View All Structures (2)

External Link

R&D Status

10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Breast Cancer
JP
04 Dec 1981
Leukemia
JP
04 Jun 1981
Lung Cancer
JP
04 Jun 1981
Lymphoma
JP
04 Jun 1981
Ovarian Cancer
JP
04 Jun 1981
Stomach Cancer
JP
04 Jun 1981
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
67
(uqqvshfggk) = qoidgcllkg dcqgvenquq (uikhlyfjmj )
Positive
14 May 2024
(uqqvshfggk) = jdqswctzqj dcqgvenquq (uikhlyfjmj )
Not Applicable
535
(yxfcfvxybz) = owiowizpda rlbxnfmyjk (vetvktzmsv )
-
29 Nov 2018
(yxfcfvxybz) = jggfqygnsk rlbxnfmyjk (vetvktzmsv )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free